Overview
Lobbying Costs
75,000€
Financial year: Jan 2014 - Nov 2014
Lobbyists (Full time equivalent)
None declared
Lobbyists with EP accreditation
6
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Alexion Pharmaceuticals (Alexion)
EU Transparency Register
611074012464-89 First registered on 18 Dec 2013
Goals / Remit
Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening diseases that are also ultra-rare. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope.
Our first commercial product is Soliris® (eculizumab), the world's first and only approved terminal complement inhibitor. Today, Soliris is approved in nearly 50 countries as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH), and in the United States, European Union, Japan and other countries as a treatment for patients with atypical hemolytic uremic syndrome (aHUS). Both PNH and aHUS are life-threatening, ultra-rare diseases that are caused by chronic uncontrolled complement activation.Main EU files targeted
Address
Head Office
Knotter Drive
Cheshire, CT 06410
UNITED STATES -
People
Total lobbyists declared
None declared
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
6 accreditations were / are live (in bold) for the selected state of 21 Nov 2014
Name Start date End Date Matthias Heck 28 Jun 2023 27 Jun 2024 Matthias Heck 14 Feb 2020 01 Mar 2021 Matthias Heck 02 Aug 2018 01 Sep 2019 Claire ALBANO 17 Oct 2017 08 Jun 2018 Mr Thibault, Marie Bruno De Lary de Latour 17 Oct 2017 21 Sep 2018 Matthias Heck 27 Jun 2017 21 Jun 2018 Claire ALBANO 22 Oct 2016 17 Oct 2017 Mr Thibault, Marie Bruno De Lary de Latour 22 Oct 2016 17 Oct 2017 Mr Gregory KALBAUGH 30 Sep 2016 23 Sep 2017 Mr David Newman 22 Aug 2016 30 Jul 2017 Matthias Heck 20 Feb 2016 19 Feb 2017 Ms Heidi Wagner 29 Oct 2015 23 Oct 2016 Claire ALBANO 29 Oct 2015 22 Oct 2016 Mr Thibault, Marie Bruno De Lary de Latour 29 Oct 2015 22 Oct 2016 Ms Grainne Madeline Crowley 29 Oct 2015 23 Oct 2016 Mr Gregory KALBAUGH 04 Sep 2015 02 Sep 2016 Ms Grainne Madeline Crowley 20 Nov 2014 29 Oct 2015 Mr Thibault, Marie Bruno De Lary de Latour 20 Nov 2014 29 Oct 2015 Mrs Grainne Madeline Crowley 20 Nov 2014 27 Jan 2015 Ms Heidi Wagner 19 Nov 2014 29 Oct 2015 Mr André Zöller 19 Nov 2014 29 Jul 2015 Claire ALBANO 19 Nov 2014 29 Oct 2015 Complementary Information
None declared
Person in charge of EU relations
None declared
Person with legal responsibility
Heidi Wagner (Senior Vice President Global Government Affairs)
-
Categories
Category
II - In-house lobbyists and trade/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
None declared
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2014 - Nov 2014
Lobbying costs for closed financial year
75,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
None declared
Communication activities
None declared
Other activities
None declared
Meetings
Meetings
None declared